About Kanagawa Cancer Center
神奈川県立がんセンターは、神奈川県横浜市旭区にある医療機関。地方独立行政法人神奈川県立病院機構が運営する病院である。都道府県がん診療連携拠点病院に指定されている。 2013年11月2日に新病院が開院し、2015年12月15日に重粒子線治療装置の治療を開始した。
Clinical Trials at Kanagawa Cancer Center
During the past decade, Kanagawa Cancer Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kanagawa Cancer Center
According to Clinical.Site data, the most researched conditions in "Kanagawa Cancer Center" are
"Biliary Tract Cancer" (1 trials), "Bladder Cancer" (1 trials), "Head and Neck Squamous Cell Carcinoma (HNSCC)" (1 trials), "Lung Neoplasms" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Kanagawa Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Kanagawa Cancer Center
Most popular intervention types in "Kanagawa Cancer Center" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials), "BI 754091" (1 trials) and "BI 754111" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kanagawa Cancer Center
The vast majority of trials in "Kanagawa Cancer Center" are
5 trials for "All" genders.
Clinical Trials Status at Kanagawa Cancer Center
Currently, there are NaN active trials in "Kanagawa Cancer Center".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kanagawa Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kanagawa Cancer Center, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".